{"2412.20373": {"publish_time": "2024-12-29", "title": "A Deep Subgrouping Framework for Precision Drug Repurposing via Emulating Clinical Trials on Real-world Patient Data", "paper_summary": "Drug repurposing identifies new therapeutic uses for existing drugs, reducing\nthe time and costs compared to traditional de novo drug discovery. Most\nexisting drug repurposing studies using real-world patient data often treat the\nentire population as homogeneous, ignoring the heterogeneity of treatment\nresponses across patient subgroups. This approach may overlook promising drugs\nthat benefit specific subgroups but lack notable treatment effects across the\nentire population, potentially limiting the number of repurposable candidates\nidentified. To address this, we introduce STEDR, a novel drug repurposing\nframework that integrates subgroup analysis with treatment effect estimation.\nOur approach first identifies repurposing candidates by emulating multiple\nclinical trials on real-world patient data and then characterizes patient\nsubgroups by learning subgroup-specific treatment effects. We deploy \\model to\nAlzheimer's Disease (AD), a condition with few approved drugs and known\nheterogeneity in treatment responses. We emulate trials for over one thousand\nmedications on a large-scale real-world database covering over 8 million\npatients, identifying 14 drug candidates with beneficial effects to AD in\ncharacterized subgroups. Experiments demonstrate STEDR's superior capability in\nidentifying repurposing candidates compared to existing approaches.\nAdditionally, our method can characterize clinically relevant patient subgroups\nassociated with important AD-related risk factors, paving the way for precision\ndrug repurposing.", "paper_summary_zh": "\u836f\u7269\u518d\u5229\u7528\u4e3a\u73b0\u6709\u836f\u7269\u627e\u51fa\u65b0\u7684\u6cbb\u7597\u7528\u9014\uff0c\u4e0e\u4f20\u7edf\u7684\u4ece\u5934\u836f\u7269\u53d1\u73b0\u76f8\u6bd4\uff0c\u51cf\u5c11\u4e86\u65f6\u95f4\u548c\u6210\u672c\u3002\u5927\u591a\u6570\u4f7f\u7528\u771f\u5b9e\u4e16\u754c\u60a3\u8005\u6570\u636e\u7684\u73b0\u6709\u836f\u7269\u518d\u5229\u7528\u7814\u7a76\u901a\u5e38\u5c06\u6574\u4e2a\u4eba\u7fa4\u89c6\u4e3a\u540c\u8d28\u7684\uff0c\u800c\u5ffd\u7565\u4e86\u4e0d\u540c\u60a3\u8005\u4e9a\u7ec4\u6cbb\u7597\u53cd\u5e94\u7684\u5f02\u8d28\u6027\u3002\u8fd9\u79cd\u65b9\u6cd5\u53ef\u80fd\u4f1a\u5ffd\u89c6\u5bf9\u7279\u5b9a\u4e9a\u7ec4\u6709\u76ca\u4f46\u6574\u4e2a\u7fa4\u4f53\u7f3a\u4e4f\u663e\u7740\u6cbb\u7597\u6548\u679c\u7684\u6709\u5e0c\u671b\u7684\u836f\u7269\uff0c\u4ece\u800c\u53ef\u80fd\u9650\u5236\u5df2\u8bc6\u522b\u7684\u53ef\u518d\u5229\u7528\u5019\u9009\u836f\u7269\u7684\u6570\u91cf\u3002\u4e3a\u4e86\u89e3\u51b3\u8fd9\u4e2a\u95ee\u9898\uff0c\u6211\u4eec\u5f15\u5165\u4e86 STEDR\uff0c\u8fd9\u662f\u4e00\u4e2a\u65b0\u9896\u7684\u836f\u7269\u518d\u5229\u7528\u6846\u67b6\uff0c\u5b83\u5c06\u4e9a\u7ec4\u5206\u6790\u4e0e\u6cbb\u7597\u6548\u679c\u4f30\u8ba1\u76f8\u7ed3\u5408\u3002\u6211\u4eec\u7684\u65b9\u6cd5\u9996\u5148\u901a\u8fc7\u6a21\u62df\u771f\u5b9e\u4e16\u754c\u60a3\u8005\u6570\u636e\u7684\u591a\u4e2a\u4e34\u5e8a\u8bd5\u9a8c\u6765\u8bc6\u522b\u518d\u5229\u7528\u5019\u9009\u836f\u7269\uff0c\u7136\u540e\u901a\u8fc7\u5b66\u4e60\u4e9a\u7ec4\u7279\u5f02\u6027\u6cbb\u7597\u6548\u679c\u6765\u8868\u5f81\u60a3\u8005\u4e9a\u7ec4\u3002\u6211\u4eec\u90e8\u7f72\\model\u5230\u963f\u5c14\u8328\u6d77\u9ed8\u75c5 (AD)\uff0c\u8fd9\u662f\u4e00\u79cd\u5df2\u83b7\u6279\u836f\u7269\u8f83\u5c11\u4e14\u6cbb\u7597\u53cd\u5e94\u5df2\u77e5\u5f02\u8d28\u6027\u7684\u75be\u75c5\u3002\u6211\u4eec\u5728\u4e00\u4e2a\u8986\u76d6\u8d85\u8fc7 800 \u4e07\u60a3\u8005\u7684\u5927\u89c4\u6a21\u771f\u5b9e\u4e16\u754c\u6570\u636e\u5e93\u4e0a\u6a21\u62df\u4e86\u8d85\u8fc7\u4e00\u5343\u79cd\u836f\u7269\u7684\u8bd5\u9a8c\uff0c\u786e\u5b9a\u4e86 14 \u79cd\u5728\u8868\u5f81\u7684\u4e9a\u7ec4\u4e2d\u5bf9 AD \u6709\u76ca\u7684\u5019\u9009\u836f\u7269\u3002\u5b9e\u9a8c\u8868\u660e\uff0c\u4e0e\u73b0\u6709\u65b9\u6cd5\u76f8\u6bd4\uff0cSTEDR \u5728\u8bc6\u522b\u518d\u5229\u7528\u5019\u9009\u836f\u7269\u65b9\u9762\u5177\u6709\u66f4\u5f3a\u7684\u80fd\u529b\u3002\u6b64\u5916\uff0c\u6211\u4eec\u7684\u65b9\u6cd5\u53ef\u4ee5\u8868\u5f81\u4e0e\u91cd\u8981\u7684 AD \u76f8\u5173\u5371\u9669\u56e0\u7d20\u76f8\u5173\u7684\u4e34\u5e8a\u76f8\u5173\u60a3\u8005\u4e9a\u7ec4\uff0c\u4e3a\u7cbe\u51c6\u836f\u7269\u518d\u5229\u7528\u94fa\u5e73\u9053\u8def\u3002", "author": "Seungyeon Lee et.al.", "authors": "Seungyeon Lee, Ruoqi Liu, Feixiong Cheng, Ping Zhang", "id": "2412.20373v1", "paper_url": "http://arxiv.org/abs/2412.20373v1", "repo": "null"}}